RAD December 2022 Abstracts and Posters
All accepted abstracts have been published in The British Journal of Dermatology, Volume 188, Issue Supplement 2, February 2023. You may access the publication at: https://academic.oup.com/bjd/issue/188/Supplement_2#348 - Development and Validation of a Claims-based Algorithm for Moderate-to-Severe Atopic Dermatitis Using U.S. Real-World Data
Andrea K. Chomistek, Jessica M. Franklin, Rachel Sobel, Andrea Marcus, Sarah-Jo Sinnott, Ashley Howell, Ihtisham Sultan, Jonathan I. Silverberg, Florence T. Wang
#350 - Examining the Relationships Among Abrocitinib Treatment, Itch, Skin Pain, and Work and Activity Impairments in Patients With Atopic Dermatitis: A Mediation Modeling Analysis
Jonathan I. Silverberg, Sonja Ständer, Jacob P. Thyssen, Brian S. Kim, Carla Castro, Anthony Bewley, Laurent Misery, Andrew G. Bushmakin, Joseph C. Cappelleri, Erman Guler, Justine Alderfer, Melisa Watkins, Gary Chan, Daniela E. Myers
#351 - Examining the Relationships Among Abrocitinib Treatment, Itch, Skin Pain, and Dermatology-specific Quality of Life in Patients With Atopic Dermatitis: A Mediation Modeling Analysis
Jonathan I. Silverberg, Sonja Ständer, Jacob P. Thyssen, Brian S. Kim, Carla Castro, Anthony Bewley, Laurent Misery, Andrew G. Bushmakin, Joseph C. Cappelleri, Erman Guler, Justine Alderfer, Melissa Watkins, Gary Chan, Daniela E. Myers
#352 - Efficacy and Safety of Abrocitinib in Chinese Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of the JADE REGIMEN Phase 3 Trial
Hang Li, Hao Cheng, Qianjin Lu, Wei Lai, Xiaohua Tao, Gerardo A. Encinas, Shefali Vyas, Bo Wang, Xin Luo, Shiqi Li
#353 - Amlitelimab Reduces Serum IL-13 in a Phase 2a Clinical Trial in Atopic Dermatitis Without Impacting T-Cell Expansion in a T-Cell Recall Assay
Stephan Weidinger, Michael Cork, Adam Reich, Thomas Bieber, Davide Lucchesi, Natalie Rynkiewicz, Richard C A Sainson, Ron Chen, Francesca Prandi, Cassandra van Krinks, Marisa Stebegg, Ben Porter-Brown
#354 - Genital Involvement in Patients With Atopic Dermatitis is Associated With Sexual Difficulties and Higher Disease Burden: Results From a Real-World Multicountry Cohort Study (MEASURE-AD)
Kilian Eyerich, MD, PhD; Wei Jing Loo, MD; Brian M. Calimlim, DRPH, MS; Wan Ju Lee, PhD; Shirley H. Chen, PharmD; Cristina Sancho Sanchez, PharmD; Felix Lauffer, MD
#355 - Efficacy of Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Analysis of Time Spent in Skin Clearance Response States from the Measure Up 1, Measure Up 2, and Heads Up Studies
Andrew Blauvelt, Jonathan I Silverberg, Brian M Calimlim, Yingyi Liu, Andrew Platt, Jacob P Thyssen
#357 - The Effect of Upadacitinib on the Genital Region in Moderate-To-Severe Atopic Dermatitis: An Analysis from the Measure Up 1 and Measure Up 2 Studies
Jennifer Cather; Nina Magnolo; Michael Cameron; Brian Calimlim; Michael Lane; Stephanie Hays; Amy Gamelli; Yu Ri Woo
#358 - Poor correlation between clinician-reported outcomes and patient-reported outcomes is observed in non-white patients with atopic dermatitis
Jourdan Hydol Smith, BA, Jonathan I. Silverberg, MD, PhD, MPH
#359 - Switching From Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: An Analysis of Responders and Nonresponders to Dupilumab
Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Andrew E. Pink, Stephan Weidinger, Gary Chan, Irina Lazariciu, Claire Clibborn, Erman Guler